ClinicalTrials.gov
ClinicalTrials.gov Menu

Trastuzumab Plus Paclitaxel in Treating Women With Metastatic Breast Cancer That Overexpresses HER2

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00005635
Recruitment Status : Completed
First Posted : March 16, 2004
Last Update Posted : August 20, 2013
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
Genentech, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2001
  Study Completion Date : No date given